Lasix for the Prevention of De Novo Postpartum Hypertension
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
Primary objective: To evaluate whether oral furosemide can help prevent de novo postpartum
hypertension (new-onset high blood pressure after delivery) by reducing blood pressure after
delivery in high-risk women.
Secondary objectives: To evaluate whether oral furosemide administered to high-risk women
after delivery can reduce the frequency of postpartum hypertensive episodes, the need for
antihypertensive therapy, the risk of postpartum preeclampsia, and the incidence of severe
maternal morbidity.